Advances and challenges in neoantigen prediction for cancer immunotherapy
Neoantigens, derived from tumor-specific mutations, are promising targets of cancer immunotherapy by eliciting tumor-specific T-cell responses while sparing normal cells. Accurate neoantigen prediction relies on immunogenomics and immunopeptidomics. Immunogenomics identifies tumor-specific mutations...
Saved in:
| Main Authors: | Yi Zhang, Ting-Ting Chen, Xiong Li, Ai-Lin Lan, Peng-Fei Ji, Ya-Juan Zhu, Xue-Yao Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1617654/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
by: Belen Aparicio, et al.
Published: (2024-12-01) -
Neoantigen vaccines: advancing personalized cancer immunotherapy
by: Alaa A. A. Aljabali, et al.
Published: (2025-04-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01) -
Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01) -
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01)